Skip to Main Content

Author Details

Kyu-Tae Kim
Ajou University
2000
37
22
PMIDPaper TitleJournal TitlePublished Year
35790315Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer.J Immunother Cancer2022
35790315Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer.J Immunother Cancer2022
33721246Bispecific Antibody Molecule Inhibits Tumor Cell Proliferation More Efficiently Than the Two-Molecule Combination.Drugs R D2021
33846173Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer.Cancer Discov2021
33721246Bispecific Antibody Molecule Inhibits Tumor Cell Proliferation More Efficiently Than the Two-Molecule Combination.Drugs R D2021
33846173Determinants of Response and Intrinsic Resistance to PD-1 Blockade in Microsatellite Instability-High Gastric Cancer.Cancer Discov2021
30872730Intratumor heterogeneity inferred from targeted deep sequencing as a prognostic indicator.Sci Rep2019
30872730Intratumor heterogeneity inferred from targeted deep sequencing as a prognostic indicator.Sci Rep2019
29277785Establishment of a Patient-derived Xenograft for Development of Personalized HER2-targeting Therapy in Gastric Cancer.Anticancer Res2018
29208629SIDR: simultaneous isolation and parallel sequencing of genomic DNA and total RNA from single cells.Genome Res2018
29277785Establishment of a Patient-derived Xenograft for Development of Personalized HER2-targeting Therapy in Gastric Cancer.Anticancer Res2018
29208629SIDR: simultaneous isolation and parallel sequencing of genomic DNA and total RNA from single cells.Genome Res2018
28701572Clinical Application of Targeted Deep Sequencing in Solid-Cancer Patients and Utility for Biomarker-Selected Clinical Trials.Oncologist2017
28336959Affibody molecules as engineered protein drugs.Exp Mol Med2017
28701572Clinical Application of Targeted Deep Sequencing in Solid-Cancer Patients and Utility for Biomarker-Selected Clinical Trials.Oncologist2017
28474673Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer.Nat Commun2017
28263318Spatiotemporal genomic architecture informs precision oncology in glioblastoma.Nat Genet2017
28336959Affibody molecules as engineered protein drugs.Exp Mol Med2017
28474673Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer.Nat Commun2017
28263318Spatiotemporal genomic architecture informs precision oncology in glioblastoma.Nat Genet2017
27126234Deciphering intratumor heterogeneity using cancer genome analysis.Hum Genet2016
27139883Application of single-cell RNA sequencing in optimizing a combinatorial therapeutic strategy in metastatic renal cell carcinoma.Genome Biol2016
27126234Deciphering intratumor heterogeneity using cancer genome analysis.Hum Genet2016
27634761Molecular Evolution Patterns in Metastatic Lymph Nodes Reflect the Differential Treatment Response of Advanced Primary Lung Cancer.Cancer Res2016
27634761Molecular Evolution Patterns in Metastatic Lymph Nodes Reflect the Differential Treatment Response of Advanced Primary Lung Cancer.Cancer Res2016
27139883Application of single-cell RNA sequencing in optimizing a combinatorial therapeutic strategy in metastatic renal cell carcinoma.Genome Biol2016
25306393Combination of novel HER2-targeting antibody 1E11 with trastuzumab shows synergistic antitumor activity in HER2-positive gastric cancer.Mol Oncol2015
25306393Combination of novel HER2-targeting antibody 1E11 with trastuzumab shows synergistic antitumor activity in HER2-positive gastric cancer.Mol Oncol2015
26225765Affinity Maturation of Monoclonal Antibody 1E11 by Targeted Randomization in CDR3 Regions Optimizes Therapeutic Antibody Targeting of HER2-Positive Gastric Cancer.PLoS One2015
26305796Identification of Distinct Tumor Subpopulations in Lung Adenocarcinoma via Single-Cell RNA-seq.PLoS One2015
26084335Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells.Genome Biol2015
26305796Identification of Distinct Tumor Subpopulations in Lung Adenocarcinoma via Single-Cell RNA-seq.PLoS One2015
26225765Affinity Maturation of Monoclonal Antibody 1E11 by Targeted Randomization in CDR3 Regions Optimizes Therapeutic Antibody Targeting of HER2-Positive Gastric Cancer.PLoS One2015
26084335Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells.Genome Biol2015
24648706Biological effects of femtosecond-terahertz pulses on C57BL/6 mouse skin.Ann Dermatol2014
24648706Biological effects of femtosecond-terahertz pulses on C57BL/6 mouse skin.Ann Dermatol2014
23907528High-power femtosecond-terahertz pulse induces a wound response in mouse skin.Sci Rep2013
23907528High-power femtosecond-terahertz pulse induces a wound response in mouse skin.Sci Rep2013
22970245MicroRNA-16 is down-regulated in mutated FLT3 expressing murine myeloid FDC-P1 cells and interacts with Pim-1.PLoS One2012
22970245MicroRNA-16 is down-regulated in mutated FLT3 expressing murine myeloid FDC-P1 cells and interacts with Pim-1.PLoS One2012
22164296Induction of hair growth by insulin-like growth factor-1 in 1,763 MHz radiofrequency-irradiated hair follicle cells.PLoS One2011
22164296Induction of hair growth by insulin-like growth factor-1 in 1,763 MHz radiofrequency-irradiated hair follicle cells.PLoS One2011
20618997Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.BMC Cancer2010
20618997Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.BMC Cancer2010
18192505Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML.Blood2008
21828739Noise characteristics of single-walled carbon nanotube network transistors.Nanotechnology2008
18192505Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML.Blood2008
21828739Noise characteristics of single-walled carbon nanotube network transistors.Nanotechnology2008
17047150Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways.Blood2007
17359372FLT3/ITD expression increases expansion, survival and entry into cell cycle of human haematopoietic stem/progenitor cells.Br J Haematol2007
  • 1 - 50 of 74

Recommended Authors

Tuo Zhang
Weill Cornell Medical College.
Career Start Year 2013
Number of shared co-authors 0
Gabriela Alexe
Dana-Farber Cancer Institute
Career Start Year 2004
Number of shared co-authors 2
Nan Du
Institute for Solid State Physics, Friedrich Schiller University Jena
Career Start Year 2003
Number of shared co-authors 0
Reza Ghasemi
Washington University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Bin Yan
The University of Hong Kong
Career Start Year 2003
Number of shared co-authors 2
Andrew V Kossenkov
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 0
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
Fan Yang
West China Second Hospital, Sichuan University
Career Start Year 2000
Number of shared co-authors 2
Bing-Hung Chen
Kaohsiung Medical University
Career Start Year 1998
Number of shared co-authors 2
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 3
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 6
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 2
Benedikt Brors
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 2
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Agnes Viale
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Anamaria A Camargo
Hospital Sirio-Libanes
Career Start Year 1994
Number of shared co-authors 0
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 2
Ping Jin
Center for Cellular Engineering, National Institutes of Health Clinical Center
Career Start Year 1993
Number of shared co-authors 2
Nan Deng
Cedars-Sinai Medical Center
Career Start Year 1992
Number of shared co-authors 0
John Easton
St Jude Children's Research Hospital
Career Start Year 1991
Number of shared co-authors 2
Jong-Il Kim
Genomic Medicine Institute, Medical Research Center, Seoul National University
Career Start Year 1989
Number of shared co-authors 8
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 3
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 1
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 5
Enzo Medico
Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia (FPO) - IRCCS
Career Start Year 1988
Number of shared co-authors 0
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 1
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 5

Collaborators

Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 15
Donald Small
Johns Hopkins University School of Medicine
Co-authored papers 10
Mark J Levis
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Co-authored papers 7
Hae-Ock Lee
College of Medicine, The Catholic University of Korea
Co-authored papers 6
Jeeyun Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 4
Obdulio Piloto
Entopsis Inc.
Co-authored papers 4
Patrick Brown
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Co-authored papers 3
Kyoung-Mee Kim
Seoul National University College of Medicine
Co-authored papers 3
Sung Tae Kim
Busan Paik Hospital, Inje University
Co-authored papers 3
Li Li
Johns Hopkins University School of Medicine
Co-authored papers 3
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers 3
Kyeung Min Joo
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers 2
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Sang Shin
Feinberg School of Medicine, Northwestern University
Co-authored papers 2
Jeong Eon Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Hye Won Lee
Yonsei University College of Medicine, Severance Hospital
Co-authored papers 2
Kristin Baird
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Jason K Sa
Korea University, College of Medicine
Co-authored papers 2
Johan Rockberg
KTH - Royal Institute of Technology
Co-authored papers 2
Nayoung K D Kim
Samsung Genome Institute, Samsung Medical Center
Co-authored papers 2
Yun Jee Seo
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers 2
Peili Chen
University of Chicago
Co-authored papers 2
Rodney J Scott
Co-authored papers 2
Zhaoqi Liu
University of Chinese Academy of Sciences
Co-authored papers 1
Linzhao Cheng
Johns Hopkins University School of Medicine
Co-authored papers 1
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Co-authored papers 1
Pablo G Camara
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 1
Andrew X Chen
Columbia University
Co-authored papers 1
Junhyung Kim
Keimyung University School of Medicine
Co-authored papers 1
Daniel I S Rosenbloom
Merck & Co. Inc.
Co-authored papers 1
Release 1.2